A careful reading / Copper Tripeptide-1
GHK-Cu is a copper peptide studied for skin and hair, read here with an honest look at what is and is not established.
It binds copper, stimulates fibroblast collagen at picomolar concentrations, and lifts hair counts in a controlled trial — and it has no validated human pharmacokinetics. Both halves of that record, cited and laid out plainly.
GHK Copper Peptide: What the Research Shows
GHK-Cu is the glycyl-L-histidyl-L-lysine copper(II) complex — a three-amino-acid peptide bound 1:1 to a copper ion. It occurs naturally in human plasma, saliva, and urine, and the GHK sequence sits inside the alpha-2(I) chain of type I collagen, so the body already carries it [3]. Plasma GHK declines from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60, which is the observation that first drew attention to it as an age-linked repair signal [3].
The research record is unusually long for a peptide this size. Loren Pickart isolated GHK in 1973 as a plasma factor that made aged human liver tissue synthesize protein like younger tissue [6]. In the five decades since, it has been studied for collagen synthesis, hair-follicle activity, wound repair, antioxidant defense, and broad gene-expression effects. This site reads that literature carefully — leading with what was measured, attributing after, and naming the gaps where the human evidence is thin.
The headline findings are concrete. In human fibroblast cultures, collagen synthesis rose dose-dependently from 10^-12 to 10^-9 M with no change in cell number — a specific metabolic effect, not just more cells [1]. In a 6-month trial of 45 men with androgenetic alopecia, a 5-aminolevulinic-acid-plus-GHK topical raised hair count by up to 71.5 hairs versus 9.6 for placebo, with no adverse events [4]. And topical GHK-Cu increased procollagen synthesis in 70% of treated subjects versus 40% for retinoic acid in reviewed data [13]. The deeper dives live on copper peptide skin research and copper peptide hair growth research.
How Copper Peptides Work
A copper peptide is a short peptide that chelates a copper ion, and the copper is not incidental — it is most of the point. GHK-Cu acts as both a copper chaperone, delivering the metal where enzymes need it, and a pleiotropic signaling molecule that reshapes which genes a cell expresses [2][6].
At the matrix level, GHK-Cu drives dermal fibroblasts to make collagen, elastin, glycosaminoglycans, and the proteoglycan decorin, while rebalancing matrix metalloproteinases (MMP-2, MMP-9) against their TIMP inhibitors so remodeling stays constructive rather than destructive [3][6]. The bound copper enables lysyl-oxidase cross-linking of collagen and elastin and contributes superoxide-dismutase-like antioxidant activity [6].
The signaling reach is wide. Connectivity Map analyses report that GHK alters expression of about 31.2% of human genes at a 50%-or-greater change threshold — 59% up, 41% down — strongly upregulating the ubiquitin-proteasome system, DNA-repair, and antioxidant programs while suppressing NF-kB-driven inflammation [2]. Copper coordination matters: the free GHK peptide does not reproduce MMP-2 stimulation in fibroblasts, so the form a study used is worth checking [2].
Documented Copper Peptide Benefits in Research
The copper peptide benefits documented in research cluster into four areas, each with study support. Skin matrix synthesis is the best-established: GHK-Cu stimulates collagen, dermatan and chondroitin sulfate, and decorin, with placebo-controlled topical trials reporting improved density, firmness, fine lines, and wrinkle depth [3]. Hair-follicle activity is the second: copper-peptide complexes stimulated follicle activity in C3H mice [7], and a controlled human trial of a GHK-containing topical raised hair counts significantly over placebo [4].
Wound repair is the third and broadest. Across models, GHK-Cu raises collagen, elastin, VEGF, FGF-2, and NGF while suppressing free radicals, TGF-beta-1, TNF-alpha, and protein glycation, and it chemoattracts repair cells [6]. Antioxidant and anti-inflammatory activity threads through all of it — GHK-Cu suppresses NF-kB signaling and blocks copper-induced LDL oxidation in vitro [6].
The honest framing: most of this is in vitro or rodent, and the strongest human signals are small topical trials. These are research findings, not treatment outcomes — see the copper peptide side effects section for the limits that travel alongside the benefits, and the GHK-Cu research doses page for what concentrations and routes the studies actually used.
Copper Tripeptide-1 (INCI name)
Copper Tripeptide-1 is the INCI cosmetic-ingredient name for GHK-Cu — the label you find on a skincare ingredient list when a product contains the copper-peptide complex. Chemically it is identical to GHK-Cu: glycyl-L-histidyl-L-lysine chelated to copper(II), molecular weight 402.92 Da, CAS 89030-95-5 [3].
The distinction worth holding is regulatory, not chemical. Topical Copper Tripeptide-1 is a legal, widely marketed cosmetic ingredient with a long safety record on skin [3]. Injectable, oral, or other systemic GHK-Cu is a different matter — unapproved by any regulator and studied only in research contexts. This site treats the cosmetic-topical literature and the systemic-research literature as the separate evidence bases they are.
Frequently asked, briefly
A few definitional questions come up constantly; the full set lives on the frequently asked questions about GHK-Cu page.
What does a GHK-Cu peptide do?
GHK-Cu is a copper-binding tripeptide that, at picomolar-to-nanomolar levels, stimulates fibroblast synthesis of collagen, elastin, glycosaminoglycans, and decorin and broadly modulates wound-repair, antioxidant, and matrix-remodeling pathways [1][3]. Its reach extends to gene expression: it alters a large fraction of the human transcriptome toward repair and protein-quality-control programs [2].
What is GHK-Cu and how does it work?
It is the glycyl-histidyl-lysine copper(II) complex, acting as both a copper chaperone and a pleiotropic signaling molecule. Gene-expression analyses report it alters about 31.2% of human genes at a 50%-or-greater change threshold [2]. The copper is required for most documented activities — the free peptide does not reproduce them [2].
Is GHK-Cu peptide really anti-aging?
Plasma GHK declines from about 200 ng/mL at age 20 to about 80 ng/mL by 60, and reviews report topical GHK-Cu raised collagen in 70% of treated women versus 40% for retinoic acid [3]. The evidence is largely in vitro, rodent, and small topical trials, so the anti-aging label is research-supported but not clinically settled [3].
What is the difference between GHK and GHK-Cu?
GHK is the free tripeptide (MW 340.38); GHK-Cu is its copper(II) chelate (MW 402.92) [3]. Copper coordination is required for most documented activities — the free peptide does not reproduce MMP-2 stimulation in fibroblasts [2].